Search Images Maps Play YouTube News Gmail Drive More »
Sign in
Screen reader users: click this link for accessible mode. Accessible mode has the same essential features but works better with your reader.

Patents

  1. Advanced Patent Search
Publication numberUS2558395 A
Publication typeGrant
Publication dateJun 26, 1951
Filing dateMar 26, 1948
Priority dateJun 3, 1947
Also published asDE915973C
Publication numberUS 2558395 A, US 2558395A, US-A-2558395, US2558395 A, US2558395A
InventorsAndre Studer
Original AssigneeHoffmann La Roche
Export CitationBiBTeX, EndNote, RefMan
External Links: USPTO, USPTO Assignment, Espacenet
Undenatured gelatin hemostatic sponge containing thrombin
US 2558395 A
Images(2)
Previous page
Next page
Description  (OCR text may contain errors)

Patented June 26, 1951 TUNITED' STATES PATENT OFFICE Andr Studerl...B.a seL Switzerland, assignor to Hoiimann-La Roche Inc., Nutley, N. J acorporation of New Jersey No Drawing. Application March 26, 1948, Serial No. 17,366: In SWitzerlandJune 3, 194.7

The present invention relates to a process for the manufacture of hemostatic tampons and bandages.

In surgery hemostatic tampons and bandages consisting of fibrinand"cellulose-derivative sponges which contain a, thrombin solution are used. These tampons and bandages are prepared for use by dipping them into a thrombin solution immediately priorto application. This mode of use requires the sponges to consist of a material insoluble in water, because otherwise they would collapse during the contact with the aqueous thrombin solution. 'Such sponges have the disadvantage of being resorbed much more slowly by the organism than water soluble sub stances. r

In order to avoid this disadvantage a soluble gelatine gel has been used in place of the said sponges. This gel is immersed in a thrombin solution immediately prior to application. However, it is difiicult and takes a considerable amount of time to obtain the complete impregnation of such gels by the thrombin solution. Furthermore, such impregnated tampons cannot be stored because the thrombin is unstable in the presence of water and its activity quickly diminishes. Again it has been found that thrombin brings about a diminution of the jellifying quality of the gelatin.

It has now been found, according to the present invention, that hemostatic tampon and bandages may be prepared from undenatured water soluble gelatin by adding thrombin to an aqueous gelatin solution, transforming the solution obtained into foam and drying the foam obtained in vacuo at a low temperature. The form of the thrombonic gelatin sponge may be adapted to the requirements of the intended use. The present process yields hemostatic tampons and bandages consisting of an easily soluble mass of gelatin and thrombin and which is of a cotton-wool like appearance. These tampons and bandages need not be dipped into a thrombin solution but may be placed on any wound without prior treatment. The new tampons and bandages quickly cause hemostasis; the blood flowing from the Wound is absorbed into the sponge, thereby dissolving the gelatin component; the thrombin which is thus released immediately causes the transformation of fibrinogen into fibrin. A fibrin film is thus formed over the wound, whereby the latter is closed and the flow of the blood is stopped. The film clings tightly to the surface of the wound, in many cases rendering the use of bandages or like means of protection unneces- The efiiciency of the tampons manufactured in accordance with the present invention may be demonstrated in vitro by the following experiment: .In a test tube (about 1 cm. internal diameterl a few tampons are loosely stamped to form a column about 5 cm. high. 5 com. of plasma of 37 C. are poured thereon. The plasma issucked into the sponge-like material and coagulates so quickly that the test tube may be turned upside down directly after filling in the plasma without any of the latter running out.

If so desired antiseptic agents may be added to the gelatin-thrombin product without influencing the activity of the tampons and bandages. Thymol, a mixture of p-hydroxybenzoic-acidmethyl and propylester, or sulfamides, such as 5-sulfanilamido-3,l-dimethyl-isoxazole, are :antiseptics which may be so used. The addition of substances accelerating cicatrization, such as panthenol, may also be found to be useful. Panthenol is the generic name for 'y-dihydroxy- 3,5 dimethyl butyric acid (3' hydroxypropyl) -amide.

The gelatin has a protective and stabilizing effect on the thrombin with which it is impregnated. It has been found, for instance, that the activity of an aqueous thrombin solution containing 5 per cent. gelatin falls away more slowly than in the case of such a solution containing no gelatin. The following table in which Th. U. stands for thrombin units (1 llh. U. being the amount of thrombin which causes 1 ccm. of plasma of bovine to coagulate within 30 seconds at a temperature of 37 0.), illustrates this fact:

5 grams of gelatin in sheets are added to 100 com. of distilled water. The mixture is heated to C. and filtered while still warm through a filter which retains bacteria. The filtrate is adjusted to a pH of 6.6. 10 com. of a thrombin solution containing 10,000 units per com. (vide supra) are added to 50 com. of the filtrate which ha been cooled down to a temperature of 20 C. (This thrombin solution may be prepared from a,

thrombin preparation showing on titration a content of 100 Th. U./mg.) The slightly turbid solution is passed through, a filter which retains bacteria. The clear solution is transformed into a voluminous foam by blowing in sterile air through a" glass plate. The froth is spread out over a sheet, frozen and dehydrated in high vacuo at low temperature.'

Example 2 70 mg. of thymol are dissolved in 100 com. warm distilled water. grams of gelatin are added to the solution and the mixture is heated to 80 C. Further working as describedin Example 1.

Example 3 20 mg. of p-hydroxybenzoylmethylester and 80 4 freeze-dried foam of an aqueous solution containing undenatured water-soluble gelatin and thrombin.

2. A preformed hemostatic sponge made by drying, at low temperature and under reduced pressure, a foam of an aqueous solution containing undenatured water-soluble gelatin and thrombin.

mg. of p-hydroxybenzoylpropylester are dissolved in 100 ccm. of distilled water. 5 mg. of gelatin are added and the mixture is heated to 80 C. Further working as described in Example 1.

Example 4 5 grams of gelatin in 90 com. distilled water are heated to 80 C. 2 grams of finely pulverised5- sulfanilamido-3,4-dimethylisoxazole are suspended in the warm solution. The solution is set to a pH of 6.6 by adding 5 to 10 com. of normal sodium hydroxide. The sulfanilamide then dissolves. The mixture is heated to 80 C. and Worked further in accordance with Example 1.

Example 5 0.2 gram of panthenol is dissolved in 100 com. of distilled water. 5 grams of gelatin are added. The mixture is heated to 80 C. and worked further in accordance with Example 1.

I claim:

1. As a ready-to-use hemostatic sponge, a

3. A preformed hemostatic sponge made by freezing a foam of an aqueous solution containing undenatured water-soluble gelatin and thrombin, and drying the frozen foam in vacuo at a low temperatur r ANDRE STUDER.

REFERENCES CITED The following references are of record in the file of this patent:

UNITED STATES PATENTS Number .Name Date 2,166,074 Reichel July 11, 1939 2,398,077 Smith Apr. 9, 1946 FOREIGN PATENTS Number Country 7 Date 474,093 Germany Mar. 26, 1929 OTHER REFERENCES Lesser, Drug and Cosmetic Industry, March,

' 1947, page 329.

Bing, Acta Pharmacol, 1947, vol. 3, page 366.

American Druggist, October, 1947, pages 9 96 and 16 8.

Correll et al., Proc. Soc. Exper. Biol.- and Medicine, 58, 233-5, March, 1945.

Bering, J. Clinical Investigation No. 4, 1944, pages 586-590.

Patent Citations
Cited PatentFiling datePublication dateApplicantTitle
US2166074 *Apr 9, 1937Jul 11, 1939Sharp & Dohme IncGelatinous colloids
US2398077 *Apr 29, 1940Apr 9, 1946Parke Davis & CoBlood coagulating product and method of obtaining same
DE474093C *Jul 30, 1927Mar 26, 1929Heyl & CoVerfahren zur Herstellung blutstillender und wundheilender Verbaende und Pflaster
Referenced by
Citing PatentFiling datePublication dateApplicantTitle
US2642375 *Aug 21, 1951Jun 16, 1953Ethicon Suture Lab IncHemostatic compositions
US2712672 *Jan 28, 1952Jul 12, 1955Calcagno LuigiProcess for preparing proteic sponges
US2718487 *Dec 18, 1951Sep 20, 1955Hoechst AgHemostatics containing reaction products of thrombin and acridines and process of preparing same
US3234091 *Jan 28, 1963Feb 8, 1966Ciba Geigy CorpShaped medicaments and process for their manufacture
US4006220 *Jun 4, 1975Feb 1, 1977Gottlieb Sheldon KCompositions and methods useful for repairing depressed cutaneous scars
US4292972 *Jul 9, 1980Oct 6, 1981E. R. Squibb & Sons, Inc.Lyophilized hydrocolloio foam
US4341207 *Aug 25, 1980Jul 27, 1982Kingsdown Medical Consultants LimitedWound dressing
US4538603 *Feb 27, 1985Sep 3, 1985E. R. Squibb & Sons, Inc.Dressings, granules, and their use in treating wounds
US5039414 *Aug 1, 1989Aug 13, 1991Mueller Marc BProcess for separating and/or recovering hydrocarbon oils from water using biodegradable absorbent sponges
US5149540 *Feb 27, 1991Sep 22, 1992Mochida Pharmaceutical Co., Ltd.Thrombin composition for oral administration
US6071301 *May 1, 1998Jun 6, 2000Sub Q., Inc.Device and method for facilitating hemostasis of a biopsy tract
US6162192 *May 1, 1998Dec 19, 2000Sub Q, Inc.System and method for facilitating hemostasis of blood vessel punctures with absorbable sponge
US6183497Jun 17, 1999Feb 6, 2001Sub-Q, Inc.Absorbable sponge with contrasting agent
US6200328Jun 16, 1999Mar 13, 2001Sub Q, IncorporatedDevice and method for facilitating hemostasis of a biopsy tract
US6261679May 22, 1998Jul 17, 2001Kimberly-Clark Worldwide, Inc.Fibrous absorbent material and methods of making the same
US6315753Mar 5, 1999Nov 13, 2001Sub-Q, Inc.System and method for facilitating hemostasis of blood vessel punctures with absorbable sponge
US6440151Jun 6, 2000Aug 27, 2002Sub-Q, Inc.Device and method for facilitating hemostasis of a biopsy tract
US6440153Sep 14, 2001Aug 27, 2002Sub-Q, Inc.Device and method for facilitating hemostasis of a biopsy tract
US6447534Mar 13, 2001Sep 10, 2002Sub-Q, Inc.Device and method for facilitating hemostasis of a biopsy tract
US6527734Aug 7, 2001Mar 4, 2003Sub-Q, Inc.System and method for facilitating hemostasis of blood vessel punctures with absorbable sponge
US6540735May 12, 2000Apr 1, 2003Sub-Q, Inc.System and method for facilitating hemostasis of blood vessel punctures with absorbable sponge
US6544236Oct 13, 2000Apr 8, 2003Sub-Q, IncorporatedDevice, system and method for improving delivery of hemostatic material
US6603054Apr 26, 2001Aug 5, 2003Kimberly-Clark Worldwide, Inc.Fibrous absorbent material and methods of making the same
US6610026Mar 16, 2001Aug 26, 2003Sub-Q, Inc.Method of hydrating a sponge material for delivery to a body
US6846320Sep 24, 2001Jan 25, 2005Sub-Q, Inc.Device and method for facilitating hemostasis of a biopsy tract
US6849232Mar 12, 2002Feb 1, 2005Sub-Q, Inc.Methods for sterilizing cross-linked gelatin compositions
US6863680Nov 8, 2001Mar 8, 2005Sub-Q, Inc.System and method for delivering hemostasis promoting material to a blood vessel puncture site by fluid pressure
US6964658Feb 14, 2003Nov 15, 2005Sub-Q, Inc.System and method for facilitating hemostasis of blood vessel punctures with absorbable sponge
US6984219May 18, 2001Jan 10, 2006Mark AshbyDepth and puncture control for blood vessel hemostasis system
US7008440Sep 26, 2002Mar 7, 2006Sub-Q, Inc.System and method for delivering hemostasis promoting material to a blood vessel puncture site by fluid pressure
US7029489Jun 13, 2003Apr 18, 2006Sub-Q, Inc.System and method for delivering hemostasis promoting material to a blood vessel puncture site
US7037322Jun 13, 2003May 2, 2006Sub-Q, Inc.System and method for delivering hemostasis promoting material to a blood vessel puncture with a staging tube
US7037323Dec 9, 2003May 2, 2006Sub-Q, Inc.Pledget-handling system and method for delivering hemostasis promoting material to a blood vessel puncture site by fluid pressure
US7048710Jul 11, 2000May 23, 2006Sub-Q, Inc.System and method for facilitating hemostasis of blood vessel punctures with absorbable sponge
US7175646Mar 25, 2002Feb 13, 2007Boston Scientific Scimed, Inc.Apparatus and method for percutaneous sealing of blood vessel punctures
US7192436May 28, 2004Mar 20, 2007Sub-Q, Inc.Pledget-handling system and method for delivering hemostasis promoting material to a blood vessel puncture site by fluid pressure
US7201725Sep 25, 2000Apr 10, 2007Sub-Q, Inc.Device and method for determining a depth of an incision
US7264772Oct 5, 2004Sep 4, 2007Boston Scientific Scimed, Inc.Methods for sterilizing cross-linked gelatin compositions
US7335219Jun 12, 2003Feb 26, 2008Sub-Q, Inc.Hemostatic device including a capsule
US7435425Jul 17, 2001Oct 14, 2008Baxter International, Inc.Dry hemostatic compositions and methods for their preparation
US7547446Jun 21, 2007Jun 16, 2009Baxter International, Inc.Dry hemostatic compositions and methods for their preparation
US7611479Dec 13, 2002Nov 3, 2009Sub-Q, Inc.System and method for facilitating hemostasis of blood vessel punctures with absorbable sponge
US7618567Oct 29, 2004Nov 17, 2009Boston Scientific Scimed, Inc.Absorbable sponge with contrasting agent
US7621936Jan 9, 2004Nov 24, 2009Boston Scientific Scimed, Inc.Sheath-mounted arterial plug delivery device
US7625352Jul 24, 2000Dec 1, 2009Sub-Q, Inc.Depth and puncture control for system for hemostasis of blood vessel
US7695492Jun 12, 2003Apr 13, 2010Boston Scientific Scimed, Inc.Enhanced bleed back system
US7753872Jan 29, 2003Jul 13, 2010Boston Scientific Scimed, Inc.Device, system and method for improving delivery of hemostatic material
US7871637Sep 21, 2007Jan 18, 2011Baxter International Inc.Dry hemostatic compositions and methods for their preparation
US7875043Dec 8, 2004Jan 25, 2011Sub-Q, Inc.Cinching loop
US7923031Jan 28, 2005Apr 12, 2011Ferrosan Medical Devices A/SHaemostatic sprays and compositions
US7923431Dec 23, 2002Apr 12, 2011Ferrosan Medical Devices A/SHaemostatic kit, a method of preparing a haemostatic agent and a method of promoting haemostatis
US7955288Dec 11, 2003Jun 7, 2011Ferrosan Medical Devices A/SGelatine-based materials as swabs
US7955353Jun 12, 2003Jun 7, 2011Sub-Q, Inc.Dissolvable closure device
US8021684Jul 7, 2005Sep 20, 2011Ferrosan Medical Devices A/SHaemostatic composition comprising hyaluronic acid
US8050741Dec 21, 2004Nov 1, 2011Boston Scientific Scimed, Inc.Device and method for facilitating hemostasis of a biopsy tract
US8092820May 19, 2009Jan 10, 2012Baxter International Inc.Dry hemostatic compositions and methods for their preparation
US8187625Feb 4, 2002May 29, 2012Boston Scientific Scimed, Inc.Cross-linked gelatin composition comprising a wetting agent
US8283320Apr 7, 2011Oct 9, 2012Ferrosan Medical Devices A/SHaemostatic kit, a method of preparing a haemostatic agent and a method of promoting haemostasis
US8303981Jul 1, 2011Nov 6, 2012Baxter International Inc.Fragmented polymeric compositions and methods for their use
US8317821Jun 12, 2003Nov 27, 2012Boston Scientific Scimed, Inc.Release mechanism
US8357378May 24, 2011Jan 22, 2013Baxter International Inc.Fragmented polymeric compositions and methods for their use
US8383141Jul 21, 2008Feb 26, 2013Baxter International Inc.Dry hemostatic compositions and methods for their preparation
US8475812Mar 2, 2009Jul 2, 2013Omrix Biopharmaceuticals Ltd.Gelatin sponge comprising an active ingredient, its preparation and use
US8512729Oct 31, 2012Aug 20, 2013Baxter International Inc.Fragmented polymeric compositions and methods for their use
US8524270May 22, 2012Sep 3, 2013Boston Scientific Scimed, Inc.Cross-linked gelatin composition coated with a wetting agent
US8603511Jan 18, 2013Dec 10, 2013Baxter International, Inc.Fragmented polymeric compositions and methods for their use
US8623842Sep 26, 2007Jan 7, 2014Hemostasis, LlcHemostatic agent and method
US8642831Feb 27, 2009Feb 4, 2014Ferrosan Medical Devices A/SDevice for promotion of hemostasis and/or wound healing
US20110014290 *Sep 22, 2010Jan 20, 2011Boston Scientific Scimed, Inc.System and method for facilitating hemostasis with an absorbable sponge
US20130096062 *Oct 10, 2012Apr 18, 2013Baxter Healthcare S.A.Hemostatic compositions
EP0044624A1 *Jun 23, 1981Jan 27, 1982E.R. Squibb & Sons, Inc.Lyophilized hydrocolloid foam
EP1414370A1 *Jun 21, 2002May 6, 2004Baxter Healthcare S.A.Dry hemostatic compositions and methods for their preparation
EP1572004A2 *Nov 4, 2003Sep 14, 2005Sub Q, Inc.Apparatus and method for inhibiting blood loss
EP1803417A1 *Jun 21, 2002Jul 4, 2007Baxter International Inc.Dry hemostatic compositions and methods for their preparation
Classifications
U.S. Classification424/423, 106/122, 514/802, 424/94.64
International ClassificationA61L15/64, C08J9/28, A61L15/32, A61L15/42
Cooperative ClassificationA61L15/32, A61L15/64, C08J9/28, Y10S514/802, C08J2389/00, A61L15/425, A61L2400/04
European ClassificationA61L15/64, C08J9/28, A61L15/32, A61L15/42E